BiondVax's IPO

BiondVax raised a round of funding on May 12, 2015. Investors include Public.

BiondVax is a clinical stage biopharmaceutical company focused on developing and, ultimately, commercializing immunomodulation therapies for infectious diseases. The company's current product candidat…

Articles about BiondVax's IPO: